- R&D Pipeline
- Season 2 (2021-2030)
| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | Discovery the preclinical candidate for amyotrophic lateral sclerosis (ALS) based on the activation of lysosomes using small-molecular proteins | ||||||
| Peptide | Amyotrophic lateral sclerosis | Zn2+ | Candidate | ZINCURE | RS-2023-00218770 | ||
| 2 | Discovery of a novel lead compound for chronic pain treatments using a TRPV1 binding peptides design and manufacture platform | ||||||
| Peptide | Chronic Pain | TRPV1 | Lead | Gachon University | RS-2022-00167087 | ||
| 3 | Development of small molecule LRRK2 inhibitor for Parkinson’s disease treatment | ||||||
| Peptide | Parkinson's disease | LRRK2 | Candidate | Whan In Pharm. Co., Ltd. | HN21C0655 | ||